Top News
Home >> CAP TODAY Recommends

CAP TODAY Recommends

Cancer Biomarkers Conference III

Houston Methodist Department of Pathology and Genomic Medicine is presenting its Cancer Biomarkers Conference III, Sept. 15–16, at the Houston Methodist Research Institute. More than 20 speakers will cover topics such as updates on PD-L1 testing for lung cancer, urologic cancers, and melanoma, the current approach to using cytology specimens for biomarker testing, the oncologist’s approach to TKI therapy, and many more. The conference’s educational objectives include distinguishing the proper collection, management, and submission of pathology specimens for cancer …

Read More »

VIDEO SERIES: The future of the lab in health care

In a collaborative effort to discuss the future of the laboratory in health care, Bob McGonnagle, publisher of CAP TODAY, gathered with Orchard Software's Curt Johnson, chief operating officer, and Matt Modleski, chief operating officer, American Health Network. This roundtable was edited into a series of seven short videos.

Read More »

2017 Pulmonary Pathology Society 10th Biennial Meeting

Interest in lung disease has exploded in recent years due to a staggering number of developments in diagnosis and treatment. Where there was once no hope, there is now optimism and excitement. The Pulmonary Pathology Society is the world’s largest organization of experts in lung pathology. Our 2017 Biennial Meeting will take place at the University of Chicago’s Gleacher Center on Chicago’s Magnificent Mile on June 13 through 16.

Read More »

Improve triaging in the ED
A new assay delivers a higher standard of cardiac care

Improve triaging in the ED: A new assay delivers a higher standard of cardiac care. “Is it a heart attack, or something less serious?” Every day, thousands of symptomatic patients ask emergency department (ED) physicians that very question. Over the years, as diagnostic tools for acute myocardial infarction (AMI), commonly known as a heart attack, have advanced, physicians can provide increasingly accurate answers to that question. Unfortunately, diagnostic gaps still exist that can result in poor patient outcomes.

Read More »

Digital pathology association stands behind FDA’s approval of marketing whole slide imaging system

April 13, 2017—The Digital Pathology community is in full support of the FDA’s landmark announcement that Philips Whole Slide Imaging (WSI) system, IntelliSite, can be marketed for primary diagnosis. This technology facilitates review of digital surgical pathology slides with remote sign out capabilities, and poses a significant benefit to both pathologists and patients alike.

Read More »

POC testing management and integration

Dec. 2, 2016—A new white paper from Orchard Software titled “Point-of-care Testing: The Great Boom Ahead” discusses the history of POC testing connectivity and shares specific case study savings and improvements associated with the adoption of a POC testing connectivity and management solution. Read the white paper.

Read More »

What pharmacogenomics can make possible

Oct. 5, 2016—Clinical laboratories and pathology groups ought to master the emerging areas of pharmacodynamics and pharmacokinetics that open the door to a more personalized approach to drug prescribing, says a free (registration required) white paper published by Dark Daily. Read. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and ...

Read More »

Learn about molecular testing for M. pneumoniae

Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s ...

Read More »
X